Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Jul 19, 2021 10:26am
250 Views
Post# 33568866

RE:.68 is here!!!!!!!!!!!!!!

RE:.68 is here!!!!!!!!!!!!!!,,The market is firmly onto Dons misinformation,,,,his ineptness preceeds the open market trading. We are a perfect short for those who can control. Get ready for a PP at .60 or below. .55 cents is not out of the question,,,,,it all boils down to cash flow for management. They are unable to interest the investing world. And why would the investing world be interested,,really??..this clown company has produced nothing but anguish for the retail investor but lots of excitment around the personal accounts in the Calgary office. Thats easy to see hindsight. Pitiable, and a shame to other Canadian research companies which actual try to advance within their science niche!
I think the item which stands out for me is the lack of activtity around these1000 other molecules for the past two decades which are touted to be of interest in advancing humankind's defenses against disease,,,,,,all talk with no action is the give away,,which by the way,,,where we would be much better off today if they had given away these patensts around each to credibly researchers. JMO
<< Previous
Bullboard Posts
Next >>